![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 38, 29749-29753, September 22, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Aaron Diamond AIDS Research Center, The Rockefeller
University, New York, New York 10016
Human immunodeficiency virus type-1 (HIV-1)
integrase catalyzes the irreversible insertion of the viral genome into
host chromosomal DNA. We have developed a mammalian expression system
for the synthesis of authentic HIV-1 integrase in the absence of other
viral proteins. Integrase, which bears a N-terminal phenylalanine,
was found to be a short-lived protein in human embryo kidney 293T
cells. The degradation of integrase could be suppressed by proteasome
inhibitors. N-terminal phenylalanine is recognized as a degradation
signal by a ubiquitin-proteasome proteolytic system known as the N-end rule pathway. The replacement of N-terminal phenylalanine with methionine, valine, or glycine, which are stabilizing residues in the
N-end rule, resulted in metabolically stabilized integrase proteins
(half-life of N-terminal Met-integrase was at least 3 h).
Conversely, the substitution of N-terminal phenylalanine with other
destabilizing residues retained the metabolic instability of integrase.
These findings indicate that the HIV-1 integrase is a physiological
substrate of the N-end rule. We discuss a possible functional
similarity to the better understood turnover of the bacteriophage
Mu transposase and functions of integrase instability to the
maintenance and integrity of the host cell genome.
Degradation of HIV-1 Integrase by the N-end Rule Pathway*
*
This work was supported by Columbia-Rockefeller Center for
AIDS Research Grant P30 AI42848 (to M. A. M.) from NIAID,
National Institutes of Health and by internal funding from the Aaron
Diamond AIDS Research Center.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Aaron Diamond AIDS
Research Center, Rockefeller University, 455 First Ave., New York, NY
10016. Tel.: 212-448-5060; Fax: 212-448-5159; E-mail: mmuesing@adarc.org.
This article has been cited by other articles:
![]() |
A. Mousnier, N. Kubat, A. Massias-Simon, E. Segeral, J.-C. Rain, R. Benarous, S. Emiliani, and C. Dargemont von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step PNAS, August 21, 2007; 104(34): 13615 - 13620. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Chan, W.-J. Qian, D. L. Diamond, T. Liu, M. A. Gritsenko, M. E. Monroe, D. G. Camp II, R. D. Smith, and M. G. Katze Quantitative Analysis of Human Immunodeficiency Virus Type 1-Infected CD4+ Cell Proteome: Dysregulated Cell Cycle Progression and Nuclear Transport Coincide with Robust Virus Production J. Virol., July 15, 2007; 81(14): 7571 - 7583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Shun, N. K. Raghavendra, N. Vandegraaff, J. E. Daigle, S. Hughes, P. Kellam, P. Cherepanov, and A. Engelman LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration Genes & Dev., July 15, 2007; 21(14): 1767 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Perez-Caballero, T. Hatziioannou, F. Zhang, S. Cowan, and P. D. Bieniasz Restriction of Human Immunodeficiency Virus Type 1 by TRIM-CypA Occurs with Rapid Kinetics and Independently of Cytoplasmic Bodies, Ubiquitin, and Proteasome Activity J. Virol., December 15, 2005; 79(24): 15567 - 15572. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tasaki, L. C. F. Mulder, A. Iwamatsu, M. J. Lee, I. V. Davydov, A. Varshavsky, M. Muesing, and Y. T. Kwon A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons Mol. Cell. Biol., August 15, 2005; 25(16): 7120 - 7136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Llano, S. Delgado, M. Vanegas, and E. M. Poeschla Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase J. Biol. Chem., December 31, 2004; 279(53): 55570 - 55577. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. Kwon, Z. Xia, J. Y. An, T. Tasaki, I. V. Davydov, J. W. Seo, J. Sheng, Y. Xie, and A. Varshavsky Female Lethality and Apoptosis of Spermatocytes in Mice Lacking the UBR2 Ubiquitin Ligase of the N-End Rule Pathway Mol. Cell. Biol., November 15, 2003; 23(22): 8255 - 8271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Devroe, A. Engelman, and P. A. Silver Intracellular transport of human immunodeficiency virus type 1 integrase J. Cell Sci., November 1, 2003; 116(21): 4401 - 4408. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Maertens, P. Cherepanov, W. Pluymers, K. Busschots, E. De Clercq, Z. Debyser, and Y. Engelborghs LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells J. Biol. Chem., August 29, 2003; 278(35): 33528 - 33539. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Pierson, Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano Molecular Characterization of Preintegration Latency in Human Immunodeficiency Virus Type 1 Infection J. Virol., July 29, 2002; 76(17): 8518 - 8531. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. F. Mulder, L. A. Chakrabarti, and M. A. Muesing Interaction of HIV-1 Integrase with DNA Repair Protein hRad18 J. Biol. Chem., July 19, 2002; 277(30): 27489 - 27493. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. T. Kwon, Z. Xia, I. V. Davydov, S. H. Lecker, and A. Varshavsky Construction and Analysis of Mouse Strains Lacking the Ubiquitin Ligase UBR1 (E3alpha ) of the N-End Rule Pathway Mol. Cell. Biol., December 1, 2001; 21(23): 8007 - 8021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |